Abdoulaye Djimdé
#105,266
Most Influential Person Now
Researcher
Abdoulaye Djimdé's AcademicInfluence.com Rankings
Abdoulaye Djimdébiology Degrees
Biology
#8836
World Rank
#11969
Historical Rank
Parasitology
#57
World Rank
#66
Historical Rank
Download Badge
Biology
Abdoulaye Djimdé's Degrees
- Bachelors Biology University of Bamako
- Masters Parasitology University of Bamako
- PhD Medical Parasitology University of Oxford
Similar Degrees You Can Earn
Why Is Abdoulaye Djimdé Influential?
(Suggest an Edit or Addition)According to Wikipedia, Abdoulaye Djimdé is an associate professor of Microbiology and Immunology in Mali. He works on the genetic epidemiology of antimalarial drug resistance and is a Wellcome Sanger Institute International Fellow. He is Chief of the Molecular Epidemiology and Drug Resistance Unit at the University of Bamako Malaria Research and Training Centre.
Abdoulaye Djimdé's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: polymerase chain reaction methods for surveillance in Africa. (1995) (657)
- Reemergence of chloroquine-sensitive Plasmodium falciparum malaria after cessation of chloroquine use in Malawi. (2003) (522)
- A molecular marker for chloroquine-resistant falciparum malaria. (2001) (492)
- Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing (2012) (426)
- Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia (2013) (422)
- Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. (1997) (418)
- Genome-wide and fine-resolution association analysis of malaria in West Africa (2009) (394)
- Artemether-lumefantrine treatment of uncomplicated Plasmodium falciparum malaria: a systematic review and meta-analysis of day 7 lumefantrine concentrations and therapeutic response using individual patient data (2015) (342)
- A Research Agenda for Malaria Eradication: Drugs (2011) (287)
- Resistance to antifolates in Plasmodium falciparum monitored by sequence analysis of dihydropteroate synthetase and dihydrofolate reductase alleles in a large number of field samples of diverse origins. (1997) (255)
- K13-Propeller Polymorphisms in Plasmodium falciparum Parasites From Sub-Saharan Africa (2014) (234)
- Genomic epidemiology of artemisinin resistant malaria. (2016) (228)
- Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors that Affect Treatment Outcomes for P. falciparum Malaria after Artemether-Lumefantrine and Artesunate-Amodiaquine (2014) (208)
- Tools and Strategies for Malaria Control and Elimination: What Do We Need to Achieve a Grand Convergence in Malaria? (2016) (203)
- Hemoglobin C associated with protection from severe malaria in the Dogon of Mali, a West African population with a low prevalence of hemoglobin S. (2000) (200)
- malERA: An updated research agenda for malaria elimination and eradication (2017) (198)
- Clearance of drug-resistant parasites as a model for protective immunity in Plasmodium falciparum malaria. (2003) (188)
- Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria (2001) (174)
- Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria: Implications for Vaccine Development (2009) (167)
- A global network for investigating the genomic epidemiology of malaria (2008) (153)
- Intermittent Preventive Treatment of Malaria Provides Substantial Protection against Malaria in Children Already Protected by an Insecticide-Treated Bednet in Mali: A Randomised, Double-Blind, Placebo-Controlled Trial (2011) (146)
- Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. (2005) (138)
- Plasmodium malariae and P. ovale genomes provide insights into malaria parasite evolution (2017) (134)
- Understanding the pharmacokinetics of Coartem® (2009) (114)
- A barcode of organellar genome polymorphisms identifies the geographic origin of Plasmodium falciparum strains (2014) (112)
- Dynamics of Polymorphism in a Malaria Vaccine Antigen at a Vaccine-Testing Site in Mali (2007) (105)
- Characterization of Within-Host Plasmodium falciparum Diversity Using Next-Generation Sequence Data (2012) (104)
- Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria (2009) (101)
- A Research Agenda for Malaria Eradication: Basic Science and Enabling Technologies (2011) (96)
- Efficacy, safety, and selection of molecular markers of drug resistance by two ACTs in Mali. (2008) (96)
- Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial (2018) (87)
- Polymorphisms in the K13-propeller gene in artemisinin-susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali. (2015) (85)
- A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. (2007) (82)
- An Effective Method to Purify Plasmodium falciparum DNA Directly from Clinical Blood Samples for Whole Genome High-Throughput Sequencing (2011) (81)
- Community pyrimethamine-sulfadoxine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: a model for deterring resistance. (1996) (80)
- Impact of preseason treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. (2002) (78)
- Monitoring and deterring drug-resistant malaria in the era of combination therapy. (2007) (77)
- Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria (2014) (75)
- COVID-19: Shining the Light on Africa (2020) (73)
- Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study (2018) (73)
- Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial. (2011) (72)
- Major subpopulations of Plasmodium falciparum in sub-Saharan Africa (2019) (70)
- Effectiveness of seasonal malaria chemoprevention at scale in west and central Africa: an observational study (2020) (68)
- A randomized trial of artesunate-mefloquine versus artemether-lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali. (2008) (67)
- First Detection of Leishmania major DNA in Sergentomyia (Spelaeomyia) darlingi from Cutaneous Leishmaniasis Foci in Mali (2012) (67)
- No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. (2012) (67)
- Use of antimalarial drugs in Mali: policy versus reality. (1998) (65)
- The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data. (2015) (65)
- Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. (1999) (64)
- The effect of food consumption on lumefantrine bioavailability in African children receiving artemether–lumefantrine crushed or dispersible tablets (Coartem®) for acute uncomplicated Plasmodium falciparum malaria (2010) (63)
- Rapid selection of Plasmodium falciparum dihydrofolate reductase mutants by pyrimethamine prophylaxis. (2000) (60)
- Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali (2017) (59)
- Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. (2004) (58)
- Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention. (2021) (58)
- Safety and efficacy of re-treatments with pyronaridine-artesunate in African patients with malaria: a substudy of the WANECAM randomised trial (2016) (56)
- Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali (2010) (52)
- Efficacy and safety of a fixed dose artesunate-sulphamethoxypyrazine-pyrimethamine compared to artemether-lumefantrine for the treatment of uncomplicated falciparum malaria across Africa: a randomized multi-centre trial (2009) (52)
- malERA: An updated research agenda for insecticide and drug resistance in malaria elimination and eradication (2017) (52)
- Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults (2014) (51)
- Intermittent preventive treatment using artemisinin‐based combination therapy reduces malaria morbidity among school‐aged children in Mali (2009) (48)
- Sulfadoxine-pyrimethamine impairs Plasmodium falciparum gametocyte infectivity and Anopheles mosquito survival. (2010) (48)
- Population Genetic Analysis of Plasmodium falciparum Parasites Using a Customized Illumina GoldenGate Genotyping Assay (2011) (46)
- Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum. (2001) (44)
- Safety of epoietin beta-quinine drug combination in children with cerebral malaria in Mali (2009) (44)
- Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali (2009) (44)
- In Vivo and In Vitro Antimalarial Properties of Azithromycin-Chloroquine Combinations That Include the Resistance Reversal Agent Amlodipine (2011) (43)
- A randomized trial of artesunate-sulfamethoxypyrazine-pyrimethamine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Mali. (2006) (42)
- Whole-Genome Scans Provide Evidence of Adaptive Evolution in Malawian Plasmodium falciparum Isolates (2014) (42)
- Broadening Participation in the Sciences within and from Africa: Purpose, Challenges, and Prospects (2017) (41)
- Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses (2020) (40)
- Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: parasitologic resistance versus therapeutic efficacy. (2001) (40)
- Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa? (2019) (40)
- Repeated Artemisinin-Based Combination Therapies in a Malaria Hyperendemic Area of Mali: Efficacy, Safety, and Public Health Impact (2012) (39)
- Monitoring parasite diversity for malaria elimination in sub-Saharan Africa (2014) (38)
- Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives (2013) (37)
- Dermatophytosis among Schoolchildren in Three Eco-climatic Zones of Mali (2016) (36)
- Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. (2010) (35)
- Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali (2009) (35)
- Hematologic parameters in pediatric uncomplicated Plasmodium falciparum malaria in sub-Saharan Africa. (2011) (34)
- Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009 (2014) (31)
- Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis (2015) (31)
- Seasonal Malaria Chemoprevention with Sulphadoxine-Pyrimethamine and Amodiaquine Selects Pfdhfr-dhps Quintuple Mutant Genotype in Mali (2016) (31)
- Molecular markers for artemisinin and partner drug resistance in natural Plasmodium falciparum populations following increased insecticide treated net coverage along the slope of mount Cameroon: cross-sectional study (2017) (30)
- Reducing the Carbon Footprint of Academic Conferences: The Example of the American Society of Tropical Medicine and Hygiene (2020) (29)
- Baseline in vitro efficacy of ACT component drugs on Plasmodium falciparum clinical isolates from Mali. (2008) (29)
- Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria (2011) (27)
- The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data. (2015) (27)
- A molecular map of chloroquine resistance in Mali. (2010) (26)
- Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether–lumefantrine treatment in Mali (2017) (26)
- Expanding Research Capacity in Sub-Saharan Africa Through Informatics, Bioinformatics, and Data Science Training Programs in Mali (2019) (24)
- PlasmoView: A Web-based Resource to Visualise Global Plasmodium falciparum Genomic Variation (2013) (24)
- Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data (2020) (23)
- An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. (2021) (23)
- Genetic determinants of anti-malarial acquired immunity in a large multi-centre study (2015) (23)
- Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa (2012) (22)
- Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger (2016) (22)
- The importance and future of malaria research in Africa. (2004) (22)
- Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa (2012) (21)
- A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali (2018) (21)
- Toxoplasma gondii Seroprevalence in Mali (2013) (20)
- Expression of complement and toll-like receptor pathway genes is associated with malaria severity in Mali: a pilot case control study (2016) (19)
- Efficacy of chloroquine and sulfadoxine/pyrimethamine for the treatment of uncomplicated falciparum malaria in Koumantou, Mali. (2006) (19)
- Plasmodium falciparum Plasmepsin 2 Duplications, West Africa (2018) (19)
- Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger (2018) (18)
- Gametocyte clearance dynamics following oral artesunate treatment of uncomplicated falciparum malaria in Malian children (2016) (18)
- Plasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of hypermutator phenotype. (2015) (18)
- A comparison of anemia in hemoglobin C and normal hemoglobin A children with Plasmodium falciparum malaria. (2004) (18)
- The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data (2020) (18)
- Effect of artemether-lumefantrine (Coartem) on cytomegalovirus urine viral load during and following treatment for malaria in children. (2016) (17)
- Standardised versus actual white cell counts in estimating thick film parasitaemia in African children under five (2011) (17)
- Use of a pLDH-based dipstick in the diagnostic and therapeutic follow-up of malaria patients in Mali (2011) (17)
- A review of the frequencies of Plasmodium falciparum Kelch 13 artemisinin resistance mutations in Africa (2021) (16)
- Population Pharmacokinetic Properties of Sulfadoxine and Pyrimethamine: a Pooled Analysis To Inform Optimal Dosing in African Children with Uncomplicated Malaria (2018) (16)
- The emerging threat of artemisinin resistance in malaria: focus on artemether-lumefantrine (2015) (16)
- Different Plasmodium falciparum clearance times in two Malian villages following artesunate monotherapy (2020) (15)
- Adaptive differentiation of Plasmodium falciparum populations inferred from single-nucleotide polymorphisms (SNPs) conferring drug resistance and from neutral SNPs. (2010) (15)
- Surveillance of Travellers: An Additional Tool for Tracking Antimalarial Drug Resistance in Endemic Countries (2013) (15)
- Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali (2014) (14)
- Host candidate gene polymorphisms and clearance of drug-resistant Plasmodium falciparum parasites (2011) (14)
- In Vivo Efficacy and Parasite Clearance of Artesunate + Sulfadoxine-Pyrimethamine Versus Artemether-Lumefantrine in Mali. (2016) (14)
- Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study (2015) (14)
- Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method (2019) (13)
- Evaluation of seasonal malaria chemoprevention in two areas of intense seasonal malaria transmission: Secondary analysis of a household-randomised, placebo-controlled trial in Houndé District, Burkina Faso and Bougouni District, Mali (2020) (13)
- malERA: An updated research agenda for basic science and enabling technologies in malaria elimination and eradication (2017) (13)
- Quinine treatment selects the pfnhe-1 ms4760-1 polymorphism in Malian patients with Falciparum malaria. (2013) (13)
- New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali (2017) (12)
- High frequency of PfCRT 76T in two Malian villages and its prevalence in severe relative to non-severe malaria. (2011) (12)
- Molecular Detection of Microorganisms Associated with Small Mammals and Their Ectoparasites in Mali. (2020) (11)
- Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali (2015) (11)
- Haemoglobin changes and risk of anaemia following treatment for uncomplicated falciparum malaria in sub-Saharan Africa (2017) (10)
- Time for malaria control in school-age children. (2021) (10)
- Enhancing science preparedness for health emergencies in Africa through research capacity building (2020) (10)
- Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria (2018) (9)
- In vitro activity of aminosterols against dermatophytes. (2013) (9)
- Zika Virus Circulation in Mali (2020) (9)
- Epidemiology of the outbreak, vectors and reservoirs of cutaneous leishmaniasis in Mali: A systematic review and meta-analysis. (2016) (9)
- Effects of amodiaquine and artesunate on sulphadoxine-pyrimethamine pharmacokinetic parameters in children under five in Mali (2011) (9)
- Plasmodium falciparum clearance with artemisinin-based combination therapy (ACT) in patients with glucose-6-phosphate dehydrogenase deficiency in Mali (2010) (9)
- Seroprevalence and Parasite Rates of Plasmodium malariae in a High Malaria Transmission Setting of Southern Nigeria (2019) (8)
- Tailoring a Pediatric Formulation of Artemether-Lumefantrine for Treatment of Plasmodium falciparum Malaria (2015) (8)
- Analyzing Deoxyribose Nucleic Acid from Malaria Rapid Diagnostic Tests to Study Plasmodium falciparum Genetic Diversity in Mali. (2016) (8)
- [Prevalence of Plasmodium falciparum, anemia and molecular markers of chloroquine and sulfadoxine-pyriméthamine resistance in delivered women in Fana, Mali]. (2013) (7)
- Population Pharmacokinetics of Pyronaridine in Pediatric Malaria Patients (2015) (7)
- [Epidemiology of cutaneous leishmaniasis in five villages of Dogon country, Mali]. (2012) (7)
- Targeted Next Generation Sequencing for malaria research in Africa: current status and outlook (2019) (7)
- Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis (2021) (7)
- Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: a WorldWide Antimalarial Resistance Network individual participant data meta-analysis (2019) (7)
- Antimalarial stewardship programs are urgently needed for malaria elimination: a perspective (2019) (7)
- [Seasonal variability of intestinal helminths and Schistosoma haematobium in a rural area of the Sahel in Mali]. (2012) (6)
- Efficacy of artesunate–amodiaquine, dihydroartemisinin–piperaquine and artemether–lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Maradi, Niger (2018) (6)
- A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study (2015) (5)
- Listeria monocytogenes in Human Milk in Mali: A Potential Health Emergency. (2019) (5)
- Persistent Submicroscopic Plasmodium falciparum Parasitemia 72 Hours after Treatment with Artemether-Lumefantrine Predicts 42-Day Treatment Failure in Mali and Burkina Faso (2021) (5)
- [In vitro cultivation of fields isolates of Plasmodium falciparum in Mali]. (2007) (5)
- Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali (2019) (4)
- Prevalence of malaria and factors associated with infection in children aged 6 months to 9 years in Guinea: Results from a national cross-sectional study (2020) (4)
- Haematological and Biochemical Reference Values for Healthy Population of Maferinyah Rural Community in Guinea (2020) (4)
- Uptake of Plasmodium falciparum Gametocytes During Mosquito Bloodmeal by Direct and Membrane Feeding (2020) (4)
- Genomic epidemiology of the current wave of artemisinin resistant malaria (2015) (4)
- Safety and Efficacy of a Monoclonal Antibody against Malaria in Mali. (2022) (4)
- A Double-Blind Randomized Placebo-Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment (2015) (4)
- Selection of pfcrt K76 and pfmdr1 N86 Coding Alleles after Uncomplicated Malaria Treatment by Artemether-Lumefantrine in Mali (2021) (3)
- A randomized trial of dihydroartemisinin–piperaquine versus artemether–lumefantrine for treatment of uncomplicated Plasmodium falciparum malaria in Mali (2018) (3)
- Two-Year Scale-Up of Seasonal Malaria Chemoprevention Reduced Malaria Morbidity among Children in the Health District of Koutiala, Mali (2020) (3)
- In silico characterisation of putative Plasmodium falciparum vaccine candidates in African malaria populations (2021) (3)
- Development of a pediatric formulation for treatment of P. falciparum malaria: Coartem® (artemether-lumefantrine) Dispersible (2014) (3)
- Elusive Plasmodium Species Complete the Human Malaria Genome Set (2016) (3)
- Model-based assessment of Chikungunya and O’nyong-nyong virus circulation in Mali in a serological cross-reactivity context (2021) (3)
- The cardiovascular effects of amodiaquine and structurally related antimalarials: An individual patient data meta-analysis (2021) (3)
- Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples (2023) (3)
- COVID-19 in Africa: What else? (2022) (3)
- Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02A vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants. (2020) (3)
- Field assessment of SD bioline malaria species antigen detection by rapid diagnostic tests in Mali (2016) (3)
- Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso (2020) (3)
- SELECTION OF PFCRT 76T AND PFMDR1 86Y MUTANT PLASMODIUM FALCIPARUM AFTER TREATMENT OF UNCOMPLICATED MALARIA WITH ARTESUNATE-AMODIAQUINE IN REPUBLIC OF GUINEA. (2021) (2)
- Plasmodium malariae and Plasmodium falciparum comparative susceptibility to antimalarial drugs in Mali. (2021) (2)
- Differential Incidence of Malaria in Neighboring Villages in a High-Transmission Setting of Southern Mali (2022) (2)
- Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria (2022) (2)
- Cooperation in Countering Artemisinin Resistance in Africa: Learning from COVID-19 (2022) (2)
- The Anti-Circumsporozoite Antibody Response of Children to Seasonal Vaccination With the RTS,S/AS01E Malaria Vaccine (2021) (2)
- Haematological consequences of acute uncomplicated falciparum malaria: a WorldWide Antimalarial Resistance Network pooled analysis of individual patient data (2022) (2)
- PREVALENCE OF PARASITIC INFECTIONS IN CHILDREN OF BOKE, GUINEA. (2021) (2)
- Virgibacillus doumboii sp. nov., a halophilic bacterium isolated from the stool of a healthy child in Mali (2021) (2)
- Impact of Three-Year Intermittent Preventive Treatment Using Artemisinin-Based Combination Therapies on Malaria Morbidity in Malian Schoolchildren (2020) (2)
- Ex Vivo Plasmodium malariae Culture Method for Antimalarial Drugs Screen in the Field (2021) (2)
- Optimal sampling designs for accurate estimation of parasite clearance in the context of artemisinin resistance (2012) (1)
- SEASONAL MALARIA CHEMOPREVENTION WITH SULPHADOXINE-PYRIMETHAMINE AND AMODIAQUINE SELECTS DHFR-DHPS QUINTUPLE MUTANT GENOTYPE IN MALI (2017) (1)
- Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria (2014) (1)
- Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali (2022) (1)
- Monitoring of the Sensitivity In Vivo of Plasmodium falciparum to Artemether-Lumefantrine in Mali (2021) (1)
- A pooled analysis of the duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine (2019) (1)
- Sequencing SARS-CoV-2 in a malaria research laboratory in Mali, West Africa: the road to sequencing the first SARS-CoV-2 genome in Mali (2021) (1)
- Temporal distribution of Plasmodium falciparum recrudescence following artemisinin-based combination therapy: an individual participant data meta-analysis (2022) (1)
- Review Understanding the pharmacokinetics of Coartem (2009) (1)
- Efficacy and safety of a combination of azithromycin and chloroquine for the treatment of uncomplicated Plasmodium falciparum malaria in two multi-country randomised clinical trials in African adults (2014) (1)
- PF3D7_1343700 KELCH PROPELLER (K13-PROPELLER) POLYMORPHISMS AND ARTESUNATE MONOTHERAPY EFFICACY IN UNCOMPLICATED MALARIA TREATMENT IN MALI (2017) (1)
- Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives (2013) (1)
- Draft Genome Sequence of Bacillus velezensis Strain Marseille-Q1230, Isolated from a Stool Sample from a Severely Malnourished Child (2021) (1)
- Optimal sampling designs for accurate estimation of parasite clearance in the context of artemisinin resistance (2012) (1)
- LUMEFANTRINE DISPOSITION AFTER REPETITIVE TREATMENT OF UNCOMPLICATED MALARIA PATIENTS WITH ARTEMETHER-LUMEFANTRINE IN MALI (2017) (0)
- Evaluation of the Knowledge, Attitudes and Practices of the Staff of private Pharmacies in the city of Niamey and their clients on the management of Malaria in 2021 (2023) (0)
- Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
- EFFECT OF ARTESUNATE MONOTHERAPY ON PLASMODIUM FALCIPARUM IN VIVO GENOMIC EXPRESSION (2017) (0)
- COMPARISON OF AUTOMATIC AND MANUAL MEASUREMENT OF QT AND QTC INTERVALS DURING A CLINICAL PHASE III-B/ IV IN KOLLE, MALI (2017) (0)
- An In Silico Analysis of Malaria Pre-Erythrocytic-Stage Antigens Interpreting Worldwide Genetic Data to Suggest Vaccine Candidate Variants and Epitopes (2022) (0)
- IMPACT OF TREATMENT OF UNCOMPLICATED MALARIA BY AMODIAQUINE−ARTESUNATE (AS-AQ) ON PFCRT 76T AND PFMDR1 86Y MUTATIONS SELECTION IN PLASMODIUM FALCIPARUM ISOLATES, REPUBLIC OF GUINEA (2017) (0)
- Takala Implications for Vaccine Development Extreme Polymorphism in a Vaccine Antigen and Risk of Clinical Malaria (2009) (0)
- Reduced ex vivo susceptibility of Plasmodium falciparum after oral artemether–lumefantrine treatment in Mali (2017) (0)
- Variation in Neutrophil Levels and Artemisinin-Based Combination Therapy Efficacy in West-africa (2020) (0)
- Additional file 3: Table S3. of Efficacy of artemether-lumefantrine in relation to drug exposure in children with and without severe acute malnutrition: an open comparative intervention study in Mali and Niger (2016) (0)
- WEIGHT STATUS ROLE ON ANTIMALARIAL DRUG EFFICACY AND SAFETY IN SUBURBAN CHILD POPULATION IN MALI (2017) (0)
- New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali (2017) (0)
- Plasmodium malariae structure and genetic diversity in sub-Saharan Africa determined from microsatellite variants and linked SNPs in orthologues of antimalarial resistance genes (2022) (0)
- Expression of complement and toll-like receptor pathway genes is associated with malaria severity in Mali: a pilot case control study (2016) (0)
- A molecular map of CQR in Mali (2011) (0)
- PATTERNS OF MOLECULAR MARKERS OF RESISTANCE IN ‘REAL LIFE’ REPETITIVE DIHYDROARTEMISININ-PIPERAQUINE MALARIA TREATMENT: A MOLECULAR ANALYSIS OF THE WANECAM CLINICAL TRIAL PLATFORM OUTPUT (2017) (0)
- Comparison of azithromycin plus chloroquine versus artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in children in Africa: a randomized, open-label study (2015) (0)
- SNPs on ABC transporters and in vivo malaria parasite non clearance after chloroquine treatment in Malian children. (2013) (0)
- Polymorphisms in pfcrt and pfmdr1: parasite risk factors that affect treatment outcomes for falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine-Corrected version (2018) (0)
- Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali (2022) (0)
- Comparing changes in haematologic parameters occurring in patients included in randomized controlled trials of artesunate-amodiaquine vs single and combination treatments of uncomplicated falciparum in sub-Saharan Africa (2012) (0)
- Measuring the impact of seasonal malaria chemoprevention as part of routine malaria control in Kita, Mali (2017) (0)
- Professor Ogobara K. Doumbo (1956–June 9, 2018) (2018) (0)
- Genetic determinants of anti-malarial acquired immunity in a large multi-centre study (2015) (0)
- Plasmodium falciparum clearance in clinical studies of artesunate-amodiaquine and comparator treatments in sub-Saharan Africa, 1999–2009 (2014) (0)
- TIME TO SECOND AND THIRD EPISODES OF MALARIA OF DIHYDROARTEMISININ−PIPERAQUINE VS ARTESUNATE−AMODIAQUINE AND ARTESUNATE−PYRONARIDINE VS ARTEMETER−LUMEFANTRINE IN BOUGOULA HAMEAU, MALI (2017) (0)
- Abstracts of the Eighth EDCTP Forum, 6–9 November 2016 (2017) (0)
- Genome-wide SNP analysis of Plasmodium falciparum shows differentiation at drug-resistance-associated loci among malaria transmission settings in southern Mali (2022) (0)
- The estimated burden of fungal diseases in Mali. (2022) (0)
- SARS-CoV-2 seroprevalence and living conditions in Bamako (Mali): a cross-sectional multistage household survey after the first epidemic wave, 2020 (2022) (0)
- Evaluation of the effects on the QT-interval of 4 artemisinin-based combination therapies with a correction-free and heart rate-free method (2019) (0)
- Genetic diversity and drug resistance surveillance of Plasmodium falciparum for malaria elimination: is there an ideal tool for resource-limited sub-Saharan Africa? (2019) (0)
- Hands-on training in structural biology, a tool for sustainable development in Africa series 4 (2022) (0)
- Author Correction: Model-based assessment of Chikungunya and O’nyong-nyong virus circulation in Mali in a serological cross-reactivity context (2023) (0)
- Edinburgh Explorer Genetic determinants of anti-malarial acquired immunity in a large multi-centre study (2018) (0)
- Clinical tolerability of artesunate-amodiaquine versus comparator treatments for uncomplicated falciparum malaria: an individual-patient analysis of eight randomized controlled trials in sub-Saharan Africa (2012) (0)
- Targeted Next Generation Sequencing for malaria research in Africa: current status and outlook (2019) (0)
- Hepatic safety of repeated treatment with pyronaridine‐artesunate versus artemether–lumefantrine in patients with uncomplicated malaria: a secondary analysis of the WANECAM 1 data from Bobo-Dioulasso, Burkina Faso (2021) (0)
- Building a center of excellence in biomedical research in an unfavorable environment: the Malaria Research and Training Center in Mali. (2019) (0)
- Tackling malaria transmission at a single cell level in an endemic setting in sub-Saharan Africa (2022) (0)
- Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria (cid:1) (2011) (0)
- RANDOMIZED TRIAL TO ASSESS EFFECT OF REPEATED TREATMENT OF DHA-PQ AND AL ON QTC INTERVAL IN PATIENTS PRESENTING WITH UNCOMPLICATED MALARIA IN BOBO-DIOULASSO, BURKINA FASO (2017) (0)
- B cell immunophenotyping reveals decreased frequency of CD11c+ B cell expressing FcRL5+ subset in naturally malaria-exposed Fulani adults. (2019) (0)
- Overall and Gender-Specific Effects of Intermittent Preventive Treatment of Malaria with Artemisinin-Based Combination Therapies among Schoolchildren in Mali: A Three-Group Open Label Randomized Controlled Trial (2022) (0)
- A Double-Blind Randomized Placebo-Controlled Clinical Trial of Squalamine Ointment for tinea capitis Treatment (2014) (0)
- Impact of seasonal RTS,S/AS01E vaccination plus seasonal malaria chemoprevention on the nutritional status of children in Burkina Faso and Mali (2022) (0)
- OC 8721 WANECAM II – A CLINICAL TRIAL PROGRAMME TO ASSESS SAFETY, EFFICACY AND TRANSMISSION-BLOCKING PROPERTIES OF A NEW ANTIMALARIAL KAF156 (GANAPLACIDE) IN UNCOMPLICATED MALARIA IN WEST AND CENTRAL AFRICA (2019) (0)
- High prevalence of Plasmodium malariae from hospital and communities in a high malaria transmission setting of Southern Nigeria (2019) (0)
- Haematological parameters in paediatric uncomplicated falciparum malaria in Sub-Saharan Africa (2011) (0)
- [Development of anti-malarial vaccines and need for clinical trials in accordance with international standards in South Africa]. (2008) (0)
- A Novel Ex Vivo Drug Assay for Assessing the Transmission-Blocking Activity of Compounds on Field-Isolated Plasmodium falciparum Gametocytes (2022) (0)
- TO VALUE THE EFFICIENCY OF PYRONARIDINE-ARTESUNATE AND ARTEMETHER-LUMEFANTRINE IN THE TREATMENT OF UNCOMPLICATED MALARIA OF PLASMODIUM SPP. IN BURKINA FASO (2017) (0)
- PO 8269 SELECTION OF SEVEN-MUTATION PFCRT-PFMDR1 GENOTYPE AFTER SCALING-UP SEASONAL MALARIA CHEMOPREVENTION WITH SULPHADOXINE-PYRIMETHAMINE AND AMODIAQUINE IN MALI (2019) (0)
- Effect of three years’ seasonal malaria chemoprevention on molecular markers of resistance of Plasmodium falciparum to sulfadoxine-pyrimethamine and amodiaquine in Ouelessebougou, Mali (2022) (0)
- Artemisinin-based combination therapy for uncomplicated Plasmodium falciparum malaria in Mali: a systematic review and meta-analysis (2021) (0)
- School performance after intermittent preventive treatment using artemisinin-based combination (2014) (0)
- Comparative Susceptibility of Plasmodium ovale and Plasmodium falciparum Field Isolates to Reference and Lead Candidate Antimalarial Drugs in Ghana (2023) (0)
- IFNγ, TNFα polymorphisms and IFNγ serum levels are associated with the clearance of drug-resistant P. falciparum in Malian children. (2023) (0)
- Pharmacokinetic and Pharmacodynamic Characteristics of a New Pediatric Formulation of Artemether-Lumefantrine in African Children with Uncomplicated Plasmodium falciparum Malaria (2012) (0)
- Development of a pediatric formulation for treatment of P. falciparum malaria: Coartem® (artemether-lumefantrine) Dispersible (2014) (0)
- Efficacy of sulphadoxine-pyrimethamine + artesunate, sulphadoxine-pyrimethamine + amodiaquine, and sulphadoxine-pyrimethamine alone in uncomplicated falciparum malaria in Mali (2015) (0)
- Challenges in the clinical development pathway for triple and multiple drug combinations in the treatment of uncomplicated falciparum malaria (2022) (0)
- Delayed anemia assessment in patients treated with oral artemisinin derivatives for uncomplicated malaria: a pooled analysis of clinical trials data from Mali (2014) (0)
- ACTR1A has pleiotropic effects on risk of leprosy, inflammatory bowel disease and atopy (2022) (0)
- Genome-wide association study of leprosy in Malawi and Mali (2022) (0)
- Relationship between weight status and anti-malarial drug efficacy and safety in children in Mali (2019) (0)
This paper list is powered by the following services:
Other Resources About Abdoulaye Djimdé
What Schools Are Affiliated With Abdoulaye Djimdé?
Abdoulaye Djimdé is affiliated with the following schools:
